SCHEMBL4906992

SCHEMBL4906992

CCN(c1ccc(Br)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.44
HDAC8 Q9BY41 3/20 0.43
ALDH1A1 P00352 4/20 0.43
TSHR P16473 1/20 0.43
LMNA P02545 3/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
HDAC3 O15379 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
POLB P06746 2/20 0.40
TP53 P04637 2/20 0.39
HPGD P15428 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905740 0.90 ESR1 (0.56) ESR1HDAC8ALDH1A1TSHRLMNA
SCHEMBL4896026 0.87 ALDH1A1 (0.49) ESR1HDAC8ALDH1A1TSHRLMNA
SCHEMBL4903956 0.85 ESR1 (0.48) ESR1ALDH1A1LMNAL3MBTL1MAPT
SCHEMBL4906457 0.84 MCL1 (0.41) ESR1HDAC8ALDH1A1TSHRLMNA
SCHEMBL4904286 0.84 MAPT (0.45) ESR1ALDH1A1TSHRLMNATP53
SCHEMBL4898047 0.84 MAPT (0.47) ESR1HDAC8ALDH1A1TSHRLMNA
SCHEMBL4895643 0.83 HDAC8 (0.53) ESR1HDAC8ALDH1A1TSHRLMNA
SCHEMBL4906191 0.83 MMP9 (0.41) ESR1HDAC8ALDH1A1TSHRLMNA
SCHEMBL4903639 0.82 HCRTR2 (0.50) ESR1HDAC8ALDH1A1TSHRLMNA
SCHEMBL4904184 0.82 HCRTR2 (0.50) ESR1HDAC8ALDH1A1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ESR1 473/4885HDAC8 959/4885ALDH1A1 2664/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ESR1 585/4885HDAC8 882/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ESR1 585/4885HDAC8 882/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.